When you think of COVID-19 vaccines, three companies come to mind: Pfizer, Johnson & Johnson, and Moderna. However, according to a recent FiercePharma article, there’s a new vaccine in town. On Monday, Novavax completed its emergency use authorization request with the FDA for its vaccine. The protein-based shot, dubbed NVX-CoV2373, is intended for people 18 and older, and has demonstrated 90% efficacy against symptomatic disease in large trials in the U.S. and Mexico.
Better Late Than Never: Novavax Submits COVID-19 Vaccine to FDA
The protein-based shot could still be used for boosters and in people under the age of 18.
Feb 4, 2022
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
